ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 200 filers reported holding ARGENX SE in Q1 2022. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $693,198 | +57.4% | 1,410 | +24.8% | 0.02% | +63.6% |
| Q2 2023 | $440,395 | +14.0% | 1,130 | +9.0% | 0.01% | 0.0% |
| Q1 2023 | $386,365 | -6.3% | 1,037 | -4.7% | 0.01% | -8.3% |
| Q4 2022 | $412,167 | -10.2% | 1,088 | -16.3% | 0.01% | -25.0% |
| Q3 2022 | $459,000 | +21.4% | 1,300 | +30.3% | 0.02% | +23.1% |
| Q2 2022 | $378,000 | +126.3% | 998 | +88.7% | 0.01% | +160.0% |
| Q1 2022 | $167,000 | -27.1% | 529 | -19.2% | 0.01% | -28.6% |
| Q4 2021 | $229,000 | +39.6% | 655 | +20.6% | 0.01% | +16.7% |
| Q3 2021 | $164,000 | +40.2% | 543 | +39.6% | 0.01% | +20.0% |
| Q2 2021 | $117,000 | +19.4% | 389 | +9.3% | 0.01% | +25.0% |
| Q1 2021 | $98,000 | +55.6% | 356 | +66.4% | 0.00% | +33.3% |
| Q4 2020 | $63,000 | +270.6% | 214 | +239.7% | 0.00% | +200.0% |
| Q3 2020 | $17,000 | +750.0% | 63 | +600.0% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 9 | +80.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 5 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |